CD100 on NK cells enhance IFNγ secretion and killing of target cells expressing CD72

PLoS ONE

Volumn 2, Issue 9, 2007, Pages

  Mizrahi, Sa'ar ^a   Markel, Gal ^a   Porgador, Angel ^b   Bushkin, Yuri ^c   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD72 ANTIGEN; GAMMA INTERFERON; HOMODIMER; SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG; B LYMPHOCYTE ANTIGEN; CD100 ANTIGEN; CD72 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LIGAND; MONOCLONAL ANTIBODY; PHOSPHOSERINE;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL ADHESION; CELL COMMUNICATION; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TARGET CELL; ANIMAL; CELL LINE; CYTOLOGY; CYTOTOXICITY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR WEIGHT; MOUSE; NATURAL KILLER CELL; PROTEIN MULTIMERIZATION; SECRETION; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL ADHESION; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR WEIGHT; PHOSPHOSERINE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SEMAPHORINS; UP-REGULATION;

EID: 41049083711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000818     Document Type: Article

References (51)

1. Ljunggren HG, Karre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11: 237-244.
2. Long EO (1999) Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 17: 875-904.
3. Colonna M, Samaridis J (1995) Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268: 405-408.
4. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO (1995) Killer cell inbibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3: 801-809.
5. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, et al. (1995) Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol 155: 2306-2310.
6. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, et al. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799.
7. Braud VM, McMichael AJ (1999) Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical clan I molecule HLA-E. Curr Top Microbiol Immunol 244: 85-95.
8. Colonna M, Nakajima H, Navarro F, Lopez-Botet M (1999) A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 66: 375-381.
9. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, et al. (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186: 1809-1818.
10. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, et al. (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19: 197-223.
11. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
12. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-795.
13. Tessier-Lavigne M, Goodman CS (1996) The molecular biology of axon guidance. Science 274: 1123-1133.
14. Bougeret C, Mansur IG, Dastot H, Schmid M, Mahoury G, et al. (1992) Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 148: 318-323.
15. Delaire S, Elhabazi A, Bensussan A, Boumsell L (1998) CD100 is a leukocyte semaphorin. Cell Mol Life Sci 54: 1265-1276.
16. Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, et al. (1996) Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A 93: 11780-11785.
17. Kikutani H, Kumanogoh A (2003) Semaphorins in interactions between T cells and antigen-presenting cells. Nat Rev Immunol 3: 159-167.
18. Kumanogoh A, Kikutani H (2001) The CD100-CD72 interaction: a novel mechanism of immune regulation. Trends Immunol 22: 670-676.
19. Bismuth G, Boumsell L (2002) Controlling the immune system through semaphorins. Sci STKE 2002: RE4.
20. Kumanogoh A, Kikutani H (2003) Immune semaphorins: a new area of semaphorin research. J Cell Sci 116: 3463-3470.
21. Basile JR, Castilho RM, Williams VP, Gutkind JS (2006) Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci U S A 103: 9017-9022.
22. Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, et al. (2000) Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 13: 621-631.
23. Ishida I, Kumanogoh A, Suzuki K, Akahani S, Noda K, et al. (2003) Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses. Int Immunol. 15: 1027-1034.
24. Elhabazi A, Delaire S, Bensussan A, Boumsell L, Bismuth G (2001) Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated protcolysis. J Immunol 166: 4341-4347.
25. Herold C, Elhabazi A, Bismuth G, Bensussan A, Boumsell L (1996) CD100 is associated with CD45 at the surface of human. T lymphocytes. Role in T cell homotypic adhesion. J Immunol 157: 5262-5268.
26. Delaire S, Billard C, Tordjman R, Chedotal A, Elhabazi A, et al. (2001) Biological activity of soluble CD100. II. Soluble CD 100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol 166: 4348-4354.
27. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, et al. (1999) Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99: 71-80.
28. Kumanogoh A, Suzuki K, Ch'ng E, Watanabe C, Marukawa S, et al. (2002) Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells. J Immunol 169: 1175-1181.
29. Schwarting R, Castello R, Moldenhauer G, Pezzutto A, von Hoegen I, et al. (1992) Human Lyb-2 homolog CD72 is a market for progenitor B-cell leukemias. Am J Hematol 41: 151-158.
30. Kumanogoh A, Shikina T, Watanabe C, Takegahara N, Suzuki K, et al. (2005) Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment. Int Immunol 17: 1277-1282.
31. Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang Y, et al. (2000) The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in GD100-deficient mice. Immunity 13: 633-642.
32. Watanabe C, Kumanogoh A, Shi W, Suzuki K, Yamada S, et al. (2001) Enhanced immune responses in transgenic mice expressing a truncated form of the lymphocyte semaphorin CD100. J Immunol 167: 4321-4328.
33. Li M, O'Sullivan KM, Jones LK, Semple T, Kumanogoh A, et al. (2006) CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis. J Immunol 177: 3406-3412.
34. Chabbert-de Ponnat I, Marie-Cardine A, Pasterkamp RJ, Schiavon V, Tamagnone L, et al. (2005) Soluble CD100 functions on human monocytes and immature dendritic cells require-plexin C1 and plexin B1, respectively. Int Immunol 17: 439-447.
35. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, et al, (1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 187: 2065-2072.
36. Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, et al. (2002) Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 3: 1142-1149.
37. Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640.
38. Hanna J, Bechtel P, Zhai Y, Youssef F, McLachlan K, et al. (2004) Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol 173: 6547-6563.
39. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, et al. (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180: 1395-1403.
40. Robertson MJ, Soifer RJ, Wolf SF, Manley TJ, Donahue C, et al. (1992) Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 175: 779-788.
41. Billard C, Delaire S, Raffoux E, Bensussan A, Boumsell L (2000) Switch in the protein tyrosine phosphatase associated with human CD100 semaphorin at terminal B-cell differentiation stage. Blood 95: 965-972.
42. Wang X, Kumanogoh A, Watanabe C, Shi W, Yoshida K, et al. (2001) Functional soluble CD100/Sema4D released in activated lymphocytes: possible role in normal and pathologic immune responses. Blood 97: 3498-3504.
43. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, et al. (1999) Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci U S A 96: 5640-5644.
44. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
45. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, et al. (2001) Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 31: 2680-2689.
46. Pesando JM, Stucki MA (1990) AFTR: a fifth human B-cell-specific surface antigen. Hum Immunol 27: 193-207.
47. Garand R, Robillard N, Bataille R (1994) CD72 is constantly expressed in chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders. Leuk Res 18: 651-652.
48. Myers DE, Uckun FM (1995) An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia. Leuk Lymphoma 18: 119-122.
49. Shah PD, Gilbertson SM, Rowley DA (1985) Dendritic cells that have interacted with antigen are targets for natural killer cells. J Exp Med 162: 625-636.
50. Hauser WE Jr, Sharma SD, Remington JS (1982) Natural killer cells induced by acute and chronic toxoplasma infection. Cell Immunol 69: 330-346.
51. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, et al. (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195: 343-351.